Chimera Bioengineering

Chimera Bioengineering specializes in the development of engineered cell therapies for cancer treatment, focusing on CAR-T cell therapies that target and eliminate cancer cells using immune cells

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Chimera Bioengineering specializes in the development of engineered cell therapies for cancer treatment, focusing on CAR-T cell therapies that target and eliminate cancer cells using immune cells.

02Backed By1 investor

SCShangBay Capital→

03Similar Companies